Genetic Testing
Mi Molecular Intelligence Tumor Seek Test
The Mi Molecular Intelligence Tumor Seek Test uses advanced molecular techniques to analyze tumor samples, providing oncologists with crucial insights for personalized cancer treatment planning.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Formalin-fixed paraffin-embedded (FFPE) tumor tissue block.
- Results
- Results are typically available within 30 working days after sample receipt.
- Preparation
- The FFPE tissue block must contain more than 20% tumor tissue. The surface area should be a minimum of 25 mm² (5mm x 5mm). A completed Tumor Profiling Requisition Form (Form 47) and the corresponding Histopathology report are required.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the Mi Molecular Intelligence Tumor Seek Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Patients with diagnosed cancers requiring detailed genetic information for treatment planning.
- ✓Individuals with symptoms suggesting advanced disease or treatment resistance.
- ✓Patients with a family history of cancer or suspected genetic predisposition.
- ✓Oncologists seeking to identify specific tumor characteristics for personalized medicine.
- ✓Patients exploring eligibility for clinical trials based on tumor genetics.
- ✓Understanding tumor behavior through TMB and MSI analysis.
- ✓Assessing gene expression profiles via Whole Transcriptome analysis.
In plain language
What this test helps you understand
This comprehensive test measures several key components:
* Whole Exome (NGS DNA): Analyzes the coding regions of the genome to identify mutations. * MSI (Microsatellite Instability): Assesses the stability of microsatellite regions, which can indicate certain types of cancer. * TMB (Tumor Mutational Burden): Evaluates the total number of mutations within the tumor, providing insights into the tumor's behavior. * Whole Transcriptome (NGS RNA): Examines gene expression profiles to understand tumor biology.
Results from the Mi Molecular Intelligence Tumor Seek Test will be reported in a detailed format. Patients and their oncologists will receive comprehensive insights into the tumor's genetic landscape, which will aid in understanding the implications for treatment options. It is essential to discuss these results in detail with your healthcare provider for personalized guidance.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
Beta CTx Beta Crosslaps Collagen Type 1 C-Telopeptide Test
The Beta CTx test measures bone resorption markers to help assess bone health and osteoporosis risk.
Learn more →Bcell Rearrangement Detection Test
The Bcell Rearrangement Detection Test helps diagnose leukemia by identifying genetic changes in B cells. It's a key tool for hematologists and oncologists.
Learn more →Dpd Gene Mutations 5Fu Toxicity Detection Test
This genetic test identifies mutations in the DPD gene, helping predict the risk of severe side effects from the chemotherapy drug 5-fluorouracil (5FU).
Learn more →Ganciclovir Resistance Detection Test
This test checks for genetic changes in the cytomegalovirus (CMV) that may make it resistant to the antiviral medication Ganciclovir. It helps guide treatment decisions, especially for patients with weakened immune systems.
Learn more →